These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mixed cell cultures of normal and leukaemic cells. Pegrum GD; Balfour IC; Evans CA; Middleton VL J Pathol; 1973 May; 110(1):59-66. PubMed ID: 4269239 [No Abstract] [Full Text] [Related]
6. Immunity in leukemia. Gatti RA Boll Ist Sieroter Milan; 1974; 53(1):suppl:275-81. PubMed ID: 4277522 [No Abstract] [Full Text] [Related]
7. Susceptibility to leukemia: immunologic factors in Down's syndrome. Sutnick AI; London WT; Blumberg BS; Gerstley BJ J Natl Cancer Inst; 1971 Nov; 47(5):923-33. PubMed ID: 4256452 [No Abstract] [Full Text] [Related]
8. [Disorders of humoral and cellular immunity in acute adult leukemia]. Steruská M; Sakalová A; Gazová S; Drobná V; Chabronová I; Hrubisko M Vnitr Lek; 1979 Jan; 25(1):29-33. PubMed ID: 283625 [No Abstract] [Full Text] [Related]
9. Assessment of the mixed leucocyte reaction by target cell death: a study of leukaemic cells. Pegrum GD; Evans CA; Middleton VL; Balfour IC Clin Exp Immunol; 1972 Feb; 10(2):251-6. PubMed ID: 4505586 [TBL] [Abstract][Full Text] [Related]
10. Cell-mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen--relationship to immunocompetence and prognosis. Gutterman JU; Hersh EM; Mavligit GM; Freireich EJ; Rossen RD; Butler WT; McCredie KB; Bodey GP; Rodriguez V Natl Cancer Inst Monogr; 1973 Jun; 37():153-65. PubMed ID: 4576706 [No Abstract] [Full Text] [Related]
11. Immunological studies in acute leukemia. Santos GW; Anderson PN; Klein DL; Bias WB; Schacter BZ; Mullins GM; Burke PJ Trans Am Clin Climatol Assoc; 1977; 88():95-107. PubMed ID: 143105 [No Abstract] [Full Text] [Related]
12. [Research on cellular immunity in acute leukemia in childhood. Significance of skin tests]. Pietrogrande MC; Mieli G; Corona F; Ferraris G; Bardare M Minerva Pediatr; 1976 Nov; 28(37):2259-64. PubMed ID: 1069900 [No Abstract] [Full Text] [Related]
13. Cytotoxic antibody reactive with cultures of lymphoid cells: occurrence in disease and normal human sera. Herberman RB; Nam JM J Natl Cancer Inst; 1971 Aug; 47(2):489-94. PubMed ID: 5283788 [No Abstract] [Full Text] [Related]
14. An acute-leukemia antigen: correlation with clinical status. Halterman RH; Leventhal BG; Mann DL N Engl J Med; 1972 Dec; 287(25):1272-4. PubMed ID: 4508573 [No Abstract] [Full Text] [Related]
16. HL-A antigens and susceptibility to malignant hematological diseases. Richter KV; Fischer G; Menzel GR; Langfeld M; Aigte H; Rückwarth G; Freier G Haematologia (Budap); 1973; 7(2):203-9. PubMed ID: 4524911 [No Abstract] [Full Text] [Related]
17. The relationship of cellular immunity to prognosis in acute leukemia. Toki H; Takahashi Y; Nakanishi N; Naito T; Chen P; Takahashi I; Kitajima K Acta Med Okayama; 1977 Feb; 31(1):51-8. PubMed ID: 140590 [TBL] [Abstract][Full Text] [Related]
18. Sera from irradiated rabbits as a source of complement for immune cytolysis assays. Walker WS; Mills B; Mohanakumar T Transplantation; 1975 Sep; 20(3):260-2. PubMed ID: 1057809 [No Abstract] [Full Text] [Related]
20. Value of delayed hypersensitivity index in patients with malignancy. Morris DL Ann Allergy; 1977 Mar; 38(3):182-4. PubMed ID: 842905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]